scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.2337/DIACARE.26.7.2194 |
P698 | PubMed publication ID | 12832334 |
P50 | author | American Diabetes Association | Q4743610 |
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dyslipidemia | Q66291209 |
teenager | Q1492760 | ||
P304 | page(s) | 2194-2197 | |
P577 | publication date | 2003-07-01 | |
P1433 | published in | Diabetes Care | Q5270111 |
P1476 | title | Management of dyslipidemia in children and adolescents with diabetes | |
P478 | volume | 26 |
Q36360053 | A 5-Year Follow-up Study to Assess Clinical Outcomes of Patients with Diabetes Undergoing Lower Limb Angiography for Significant Peripheral Artery Disease |
Q38426319 | A Wireless Diabetes Management and Communication System |
Q43552894 | A pediatric perspective: adult problems in kids, new challenges in pediatric diabetes |
Q50895252 | A possible Fourier transform infrared-based plasma fingerprint of angiotensin-converting enzyme inhibitor-induced reversal of endothelial dysfunction in diabetic mice. |
Q37463043 | A questionnaire for determining prevalence of diabetes related foot disease (Q-DFD): construction and validation |
Q37875776 | A review of the Eurodiale studies: what lessons for diabetic foot care? |
Q34781467 | Adiposity and β-cell function: relationships differ with ethnicity and age |
Q34781491 | Age‐Related Changes in Insulin Sensitivity and β‐Cell Function Among European‐American and African‐American Women |
Q47793526 | An economic evaluation of VAC therapy compared with wound dressings in the treatment of diabetic foot ulcers |
Q39435263 | Antidiabetic Activity of a Lotus Leaf Selenium (Se)-Polysaccharide in Rats with Gestational Diabetes Mellitus |
Q43123588 | Antidyslipidemic Effect of Ocimum sanctum Leaf Extract in Streptozotocin Induced Diabetic Rats |
Q34356596 | Applicability of the ankle-brachial-index measurement as screening device for high cardiovascular risk: an observational study. |
Q35971662 | Approach to lipid screening as a risk marker for cardiovascular disease in pediatric patients with diabetes |
Q46716554 | Are there advantages with U-Albumin/U-Creatinine ratios compared with U-Albumin in monitoring diabetes? |
Q28166699 | Aspirin therapy in type 2 diabetes in a general practice in Italy |
Q34239673 | Association between vascular endothelial growth factor and hypertension in children and adolescents type I diabetes mellitus. |
Q35723697 | Atherosclerosis screening by noninvasive imaging for cardiovascular prevention: a systematic review |
Q36357072 | Atypical leg symptoms: does routine measurement of the ankle brachial pressure index (ABPI) in primary care benefit patients? |
Q47992562 | Audit of the dietetic care of patients with type 1 diabetes at a large Australian paediatric tertiary hospital and comparison with the International Society for Paediatric and Adolescent Diabetes nutrition guidelines. |
Q44295787 | Blockade of the renin-angiotensin system in African Americans with hypertension and cardiovascular disease |
Q40061300 | Can first-trimester screening program detect women at high risk for gestational diabetes mellitus? |
Q40174992 | Can the metabolic syndrome identify children with insulin resistance? |
Q35984594 | Cardiovascular complications in pediatric end-stage renal disease |
Q27009400 | Cardiovascular disease in children and adolescents with diabetes: where are we, and where are we going? |
Q36679572 | Cardiovascular disease risk in youth with diabetes mellitus |
Q46701536 | Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres |
Q79233367 | Cardiovascular risk factors in adolescents |
Q35060841 | Change in adiposity minimally affects the lipid profile in youth with recent onset type 1 diabetes |
Q37920503 | Characteristics of peripheral arterial disease and its relevance to the diabetic population |
Q51122703 | Chemiluminescence lateral flow immunoassay cartridge with integrated amorphous silicon photosensors array for human serum albumin detection in urine samples. |
Q54158544 | Circulating miR-21 and eNOS in subclinical atherosclerosis in patients with hypertension. |
Q36359500 | Clinical use and pathogenetic basis of laboratory tests for the evaluation of primary arterial hypertension |
Q51464123 | Combined use of fasting plasma glucose and glycated hemoglobin A1c in a stepwise fashion to detect undiagnosed diabetes mellitus. |
Q37234346 | Comorbidity in patients undergoing coronary artery bypass graft surgery: impact on outcome and implications for cardiac rehabilitation |
Q46707992 | Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapy |
Q35752772 | Continuous glucose monitoring: a stepping stone in the journey towards a cure for diabetes |
Q44564244 | Creating a combination antihypertensive regimen: what does the research show? |
Q37982207 | Current approaches to the treatment of hypertension in older persons |
Q80603574 | Determination of glycated hemoglobin in clinically silent hemoglobin variants |
Q36772146 | Diabetes care, glycemic control, complications, and concomitant autoimmune diseases in children with type 1 diabetes in Turkey: a multicenter study. |
Q51746953 | Diabetes mellitus concurrent with hepatic haemosiderosis in two macaws (Ara severa, Ara militaris). |
Q44371155 | Diabetes mellitus in middle-aged people is associated with increased sick leave: the BELSTRESS study |
Q47569895 | Diabetes self-management experience: a focus group study of Taiwanese patients with type 2 diabetes. |
Q30428895 | Diabetes-associated macrovascular complications: cell-based therapy a new tool? |
Q33696622 | Diabetes: cost of illness in Norway |
Q35983217 | Diabetic management in high risk patients (pregnancy, insulin pumps). |
Q36973440 | Diabetic nephropathy in children and adolescents |
Q81090368 | Diabetic nephropathy-an evaluation of potential risk factors in young patients with type 1 diabetes mellitus |
Q44534132 | Diabetic population mortality and cardiovascular risk attributable to hypertension: a decade follow-up from the Tehran Lipid and Glucose Study. |
Q34357233 | Diagnosis and treatment of diabetic foot infections |
Q37322411 | Duodenal–Jejunal Bypass Surgery Does Not Increase Skeletal Muscle Insulin Signal Transduction or Glucose Disposal in Goto–Kakizaki Type 2 Diabetic Rats |
Q38873062 | Dyslipidaemia and hypertension among adults with diabetes in rural Uganda |
Q35576079 | Dyslipidemia in Patients with Type 2 Diabetes. Relationships between Lipids, Kidney Disease and Cardiovascular Disease |
Q37067611 | Dyslipidemia in children with type 2 diabetes vs. obesity |
Q36977819 | Dyslipidemia in youth with diabetes: to treat or not to treat? |
Q59279847 | Early atherosclerosis in childhood type 1 diabetes: role of raised systolic blood pressure in the absence of dyslipidaemia |
Q33858320 | Effect of sarpogrelate treatment on the prognosis after endovascular therapy for critical limb ischemia |
Q44953752 | Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen |
Q57274310 | Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study |
Q50887228 | Efficacy of continuous subcutaneous insulin infusion in Type 1 diabetes: a 2-year perspective using the established criteria for funding from a National Health Service. |
Q34078199 | Epidemiology of type 1 diabetes |
Q40585117 | Epidemiology, treatment and costs of depression in adults with Type 2 diabetes |
Q38241744 | Executive function, adherence, and glycemic control in adolescents with type 1 diabetes: a literature review |
Q33373177 | Exercise training in the aerobic/anaerobic metabolic transition prevents glucose intolerance in alloxan-treated rats |
Q35226524 | Factors associated with higher oxytocin requirements in labor |
Q44945901 | Factors related to nephrotic-range proteinuria in late-stage chronic kidney disease patients with diabetes mellitus |
Q28220294 | Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a review |
Q34155197 | Gender differences in diabetes-related lower extremity amputations |
Q31111951 | Genetic random effects model for family data with long-term survivors: analysis of diabetic nephropathy in type 1 diabetes |
Q33249944 | Glucose testing and insufficient follow-up of abnormal results: a cohort study |
Q46790318 | Glycemic control in adolescents with type 1 diabetes mellitus improves lipid serum levels and oxidative stress. |
Q35183768 | Glycemic control, complications, and associated autoimmune diseases in children and adolescents with type 1 diabetes in Jeddah, Saudi Arabia |
Q46049651 | Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry |
Q35576082 | Haemoglobin A1c – A Marker for Complications of Type 2 Diabetes: The Experience from the UK Prospective Diabetes Study (UKPDS) |
Q44035730 | Health literacy, complication awareness, and diabetic control in patients with type 2 diabetes mellitus |
Q35974034 | Hypertension and microalbuminuria: the new detrimental duo. |
Q46032481 | Hypertensive retinopathy: incidence, risk factors, and comorbidities. |
Q41235361 | Impact of chromium dinicocysteinate supplementation on inflammation, oxidative stress, and insulin resistance in type 2 diabetic subjects: an exploratory analysis of a randomized, double-blind, placebo-controlled study |
Q33819061 | Impact of initial active engagement in self-monitoring with a telemonitoring device on glycemic control among patients with type 2 diabetes |
Q46758013 | Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes |
Q46973573 | Increased sucrose intake is not associated with a change in glucose or insulin sensitivity in people with type 2 diabetes |
Q36609772 | Insulin aspart: a review |
Q51470730 | Insulin resistance and inflammation - A further systemic complication of COPD. |
Q36918012 | Insulin: a model system for nanomedicine? |
Q35053417 | Intrauterine exposure to diabetes is a determinant of hemoglobin A(1)c and systolic blood pressure in pima Indian children |
Q35614502 | Is exercise a therapeutic tool for improvement of cardiovascular risk factors in adolescents with type 1 diabetes mellitus? A randomised controlled trial. |
Q36392685 | Is the development of diabetes with antihypertensive therapy a problem?--Pro |
Q36768104 | Less favorable body composition and adipokines in South Asians compared with other US ethnic groups: results from the MASALA and MESA studies |
Q35127306 | Levels of brain natriuretic peptide are associated with peripheral arterial disease in subjects with type-2 diabetes mellitus |
Q51245364 | Lipid Profile in Relation to Glycemic Control in Type 1 Diabetes Children and Adolescents in Bangladesh. |
Q37105165 | Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case-control study |
Q84218627 | Lipid profile and nutritional intake in children and adolescents with Type 1 diabetes improve after a structured dietician training to a Mediterranean-style diet |
Q40513962 | Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease |
Q37857087 | Macrovascular angiopathy in children and adolescents with type 1 diabetes. |
Q41669506 | Magnetic resonance imaging measures of decreased aortic strain and distensibility are proportionate to insulin resistance in adolescents with type 1 diabetes mellitus |
Q34620649 | Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy |
Q37292261 | Management of pediatric and adolescent type 2 diabetes |
Q36392677 | Management strategies for patients with hypertension and diabetes: why combination therapy is critical |
Q35886386 | Managing high-risk patients with hypertension: focus on the renin-angiotensin system |
Q45265388 | Metabolic syndrome and the older male population |
Q35686501 | Microalbuminuria in type 2 diabetics: an important, overlooked cardiovascular risk factor |
Q45325691 | Mortality Associated with Metformin Versus Sulfonylurea Initiation: A Cohort Study of Veterans with Diabetes and Chronic Kidney Disease |
Q34557730 | Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines |
Q51534526 | Neonatal respiratory morbidity in late-preterm births in pregnancies with and without gestational diabetes mellitus. |
Q51982689 | Nurses' perceived and actual level of diabetes mellitus knowledge: results of a cluster analysis. |
Q37435331 | Nutrition evidence-based guidelines for treating hyperlipidemia in children with type 1 diabetes: a case presentation. |
Q36938575 | Nutritional management in childhood and adolescent diabetes |
Q34543079 | Obesity, Glucose Intolerance and Diabetes and Their Links to Cardiovascular Disease. Implications for Laboratory Medicine |
Q22252954 | Obesity: Genetic, molecular, and environmental aspects |
Q36565874 | Outcomes from a diabetes self-management intervention for Native Hawaiians and Pacific People: Partners in Care |
Q42272320 | PED/PEA-15 controls fibroblast motility and wound closure by ERK1/2-dependent mechanisms |
Q33683628 | Pediatric endocrinologists' management of children with type 2 diabetes |
Q35963263 | Peer chart audits: a tool to meet Accreditation Council on Graduate Medical Education (ACGME) competency in practice-based learning and improvement |
Q28198594 | Perceived discrimination and use of preventive health services |
Q37910796 | Peripheral artery disease (PAD) screening in the asymptomatic population: why, how, and who? |
Q42634108 | Perspectives of patients with type 2 diabetes following a critical cardiac event - an interpretative approach |
Q41008029 | Pharmaceutical care of adolescents with diabetes mellitus type 1: the DIADEMA study, a randomized controlled trial |
Q31142279 | Physical activity in adults with and without diabetes: from the 'high-risk' approach to the 'population-based' approach of prevention. |
Q50986939 | Physiological effects of ultrasound mist on fibroblasts. |
Q42931796 | Plasma C-peptide level is inversely associated with family history of type 2 diabetes in Korean type 2 diabetic patients |
Q44417715 | Postprandial glucose, insulin and gastrointestinal hormones in healthy and diabetic subjects fed a fructose-free and resistant starch type IV-enriched enteral formula |
Q36199074 | Prediabetic obese adolescents have a more atherogenic lipoprotein profile compared with normoglycemic obese peers |
Q40362789 | Predictors of Dyslipidemia Over Time in Youth With Type 1 Diabetes: For the SEARCH for Diabetes in Youth Study |
Q24799963 | Predictors of glycemic control among patients with Type 2 diabetes: a longitudinal study |
Q36494412 | Prevalence and determinants of elevated apolipoprotein B and dense low-density lipoprotein in youths with type 1 and type 2 diabetes |
Q33317048 | Prevalence and determinants of microalbuminuria among diabetic patients in the United Arab Emirates |
Q37113661 | Prevalence and significance of cardiometabolic risk factors in children with type 1 diabetes |
Q39786811 | Prevalence, awareness, treatment and control of hypertension in Galicia (Spain) and association with related diseases. |
Q50556773 | Relationship between glycated hemoglobin A1c and cognitive function in nondemented elderly patients with type 2 diabetes. |
Q44248315 | Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL. |
Q46208453 | Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus |
Q36219240 | Risk factors of peripheral arterial disease: a case control study in Sri Lanka |
Q43420221 | Screening for gestational diabetes in the 21st century: a population-based cohort study in Israel |
Q53811490 | Selenoprotein P is not elevated in gestational diabetes mellitus. |
Q39723407 | Self-perceptions on the impact of diabetes among working adults: insights into disability prevention |
Q35176887 | Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients |
Q35046826 | Serum lipid profiles and glycemic control in adolescents and young adults with type 1 diabetes mellitus |
Q35741754 | Slowing cardiovascular disease progression in African-American patients: diabetes management |
Q38917838 | State transition model: vorapaxar added to standard antiplatelet therapy to prevent thrombosis post myocardial infarction or peripheral artery disease |
Q36123467 | Stroke in patients with diabetes and hypertension |
Q46102618 | Sugar profiles and soluble and insoluble dietary fiber contents of fruits in Thailand markets |
Q47193897 | Survival and associated risk factors in patients with diabetes and amputations caused by infectious foot gangrene. |
Q36283702 | Systemic antiatherosclerotic treatment for the peripheral arterial occlusive disease patient |
Q38030808 | Targeting hypertension in patients with cardiorenal metabolic syndrome. |
Q43263706 | The 600-step program for type 1 diabetes self-management in youth: the magnitude of the self-management task |
Q40970747 | The association between skeletal maturation and adrenal androgen levels in obese children and adolescents. |
Q33889993 | The burden of physical activity on type 2 diabetes public healthcare expenditures among adults: a retrospective study |
Q30409221 | The challenges and future considerations regarding pregnancy-related outcomes in women with pre-existing diabetes |
Q49712339 | The contribution of family history to the burden of diagnosed diabetes, undiagnosed diabetes, and prediabetes in the United States: analysis of the National Health and Nutrition Examination Survey, 2009-2014. |
Q37095574 | The economic burden of cancer in Korea in 2002. |
Q46583591 | The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study). |
Q38424292 | The emerging global epidemic of type 1 diabetes |
Q91979476 | The relation of serum nesfatin-1 level with anthropometric and metabolic parameters in children and adolescents: A prospective observational study |
Q38705802 | The relationship between diabetes, diabetes-related complications and productive activities among older Europeans |
Q25255077 | The relationship between obesity, hyperglycemia symptoms, and health-related quality of life among Hispanic and non-Hispanic white children and adolescents |
Q33393473 | Three years follow-up of screen-detected diabetic and non-diabetic subjects: who is better off? The ADDITION Netherlands study |
Q48209542 | Toe-brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuria. |
Q95816149 | Total homocysteine, diet, and lipid profiles in type 1 and type 2 diabetic and nondiabetic adolescents |
Q36783749 | Treatment of type 2 diabetes in youth |
Q33585122 | Tryptophan Metabolism in Patients With Chronic Kidney Disease Secondary to Type 2 Diabetes: Relationship to Inflammatory Markers |
Q37595136 | Type 2 diabetes in the pediatric population: Are we meeting ADA clinical guidelines in Ohio? |
Q82048576 | Type 2 diabetes mellitus in children and adolescents |
Q46926231 | Undocumented immigration status and diabetes care among Mexican immigrants in two immigration "sanctuary" areas |
Q43168054 | Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients |
Q45057356 | Why is self-monitoring reimbursed for blood glucose but not blood pressure? |
Q82861408 | [Lipid profile and anthropometrical evaluation in type 1 diabetes] |
Q36947018 | beta-cell function and anti-diabetic pharmacotherapy |
Search more.